Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339–1346

An Tang, Rémi Rabasa-Lhoret, Hélène Castel, Claire Wartelle-Bladou, Guillaume Gilbert, Karine Massicotte-Tisluck, Gabriel Chartrand, Damien Olivié, Anne-Sophie Julien, Jacques de Guise, Gilles Soulez, Jean-Louis Chiasson

Diabetes Care 2015;38(9):e150–e151

https://doi.org/10.2337/dc15-1091

Published: 10 August 2015

View article titled, Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339–1346

Journal Articles

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Diabetes Care 2015;38(7):1339–1346

https://doi.org/10.2337/dc14-2548

Published: 26 March 2015

View article titled, Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Includes: Supplementary data

Journal Articles

Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes

Aaron Leong, MD, Kaberi Dasgupta, MD, Jean-Louis Chiasson, MD, Elham Rahme, PHD

Diabetes Care 2013;36(10):3002–3008

https://doi.org/10.2337/dc12-2543

Published: 14 September 2013

View article titled, Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes

Includes: Supplementary data

Journal Articles

Early Insulin Use in Type 2 Diabetes: What are the cons?

Jean-Louis Chiasson, MD

Diabetes Care 2009;32(suppl_2):S270–S274

https://doi.org/10.2337/dc09-S321

Published: 01 November 2009

View article titled, Early Insulin Use in Type 2 Diabetes: <subtitle>What are the cons?</subtitle>

Journal Articles

Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound

Guy Cloutier, PHD, Audrey Zimmer, MSC, François T.H. Yu, MSC, Jean-Louis Chiasson, MD

Diabetes Care 2008;31(7):1400–1402

https://doi.org/10.2337/dc07-1802

Published: 01 July 2008

View article titled, Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound

Journal Articles

α-Glucosidase Inhibitors for Patients With Type 2 Diabetes: Response to van de Laar et al.

Markolf Hanefeld, MD, PHD, Robert G. Josse, MBBS, Jean-Louis Chiasson, MD

Diabetes Care 2005;28(7):1840

https://doi.org/10.2337/diacare.28.7.1840

Published: 01 July 2005

View article titled, α-Glucosidase Inhibitors for Patients With Type 2 Diabetes: <subtitle>Response to van de Laar et al.</subtitle>

Journal Articles

Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: Results of a 6-month, randomized, comparative trial

Priscilla A. Hollander, MD, Lawrence Blonde, MD, Richard Rowe, MD, Adi E. Mehta, MD, Joseph L. Milburn, MD, Kenneth S. Hershon, MD, Jean-Louis Chiasson, MD, Seymour R. Levin, MD, for the Exubera Phase III Study Group

Diabetes Care 2004;27(10):2356–2362

https://doi.org/10.2337/diacare.27.10.2356

Published: 01 October 2004

View article titled, Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: <subtitle>Results of a 6-month, randomized, comparative trial</subtitle>

Journal Articles

Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications

Marion J. Franz, RD, CDE, Co-Chair, John P. Bantle, MD, Co-Chair, Christine A. Beebe, RD, CDE, John D. Brunzell, MD, Jean-Louis Chiasson, MD, Abhimanyu Garg, MD, Lea Ann Holzmeister, RD, CDE, Byron Hoogwerf, MD, Elizabeth Mayer-Davis, PhD, RD, Arshag D. Mooradian, MD, Jonathan Q. Purnell, MD, Madelyn Wheeler, RD, CDE

Diabetes Care 2002;25(1):148–198

https://doi.org/10.2337/diacare.25.1.148

Published: 01 January 2002

View article titled, Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications

Journal Articles

The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

Jean-Louis Chiasson, MD, Lisa Naditch, MD, for the Miglitol Canadian University Investigator Group

Diabetes Care 2001;24(6):989–994

https://doi.org/10.2337/diacare.24.6.989

Published: 01 June 2001

View article titled, The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

Journal Articles

Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro)

Rémi Rabasa-Lhoret, MD, PHD, Josée Bourque, BSC, Francine Ducros, BSC, Jean-Louis Chiasson, MD

Diabetes Care 2001;24(4):625–630

https://doi.org/10.2337/diacare.24.4.625

Published: 01 April 2001

View article titled, Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro)

Journal Articles

Effect of Continuous Subcutaneous Insulin Infusion With Lispro on Hepatic Responsiveness to Glucagon in Type 1 Diabetes

Brigitte Launay, MD, Bernard Zinman, MD, Hugh D Tildesley, MD, Thomas Strack, PHD, Jean-Louis Chiasson, MD

Diabetes Care 1998;21(10):1627–1631

https://doi.org/10.2337/diacare.21.10.1627

Published: 01 October 1998

View article titled, Effect of Continuous Subcutaneous Insulin Infusion With Lispro on Hepatic Responsiveness to Glucagon in Type 1 Diabetes

Journal Articles

The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data

Jean-Louis Chiasson, MD, Roman Gomis, MD, Markolf Hanefeld, DSC, Robert G Josse, MBBS, Avraham Karasik, MD, Markku Laakso, MD, The Stop-Niddm Trial Research Group

Diabetes Care 1998;21(10):1720–1725

https://doi.org/10.2337/diacare.21.10.1720

Published: 01 October 1998

View article titled, The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data

Journal Articles

No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA_1c or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate

Thomas M S Wolever, DM, PHD, Jean-Louis Chiasson, MD, Robert G Josse, MD, John A Hunt, MD, Carol Palmason, ART, N Wilson Rodger, MD, Stuart A Ross, MD, Edmond A Ryan, MD, Meng H Tan, MD

Diabetes Care 1998;21(10):1612–1618

https://doi.org/10.2337/diacare.21.10.1612

Published: 01 October 1998

View article titled, No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA<sub>1c</sub> or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate

Journal Articles

Variation of Postprandial Plasma Glucose, Palatability, and Symptoms Associated With a Standardized Mixed Test Meal Versus 75 g Oral Glucose

Thomas M S Wolever, DM, PHD, Jean-Louis Chiasson, MD, Adele Csima, MSC, John A Hunt, MD, Carol Palmason, MSC, Stuart A Ross, MD, Edmond A Ryan, MD

Diabetes Care 1998;21(3):336–340

https://doi.org/10.2337/diacare.21.3.336

Published: 01 March 1998

View article titled, Variation of Postprandial Plasma Glucose, Palatability, and Symptoms Associated With a Standardized Mixed Test Meal Versus 75 g Oral Glucose

Journal Articles

Counterregulatory Hormone Responses After Long-Term Continuous Subcutaneous Insulin Infusion With Lispro Insulin

Elaine Y L Tsui, MD, Jean-Louis Chiasson, MD, Hugh Tildesley, MD, Annette Barnie, RN, Sari Simkins, RD, Thomas Strack, PHD, Bernard Zinman, MD

Diabetes Care 1998;21(1):93–96

https://doi.org/10.2337/diacare.21.1.93

Published: 01 January 1998

View article titled, Counterregulatory Hormone Responses After Long-Term Continuous Subcutaneous Insulin Infusion With Lispro Insulin

Journal Articles

The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance

Jean-Louis Chiasson, MD, Robert G Josse, FRCP, Lawrence A Leiter, MD, Marko Mihic, MD, David M Nathan, MD, Carol Palmason, ART, Robert M Cohen, MD, Thomas MS Wolever, DM, PHD

Diabetes Care 1996;19(11):1190–1193

https://doi.org/10.2337/diacare.19.11.1190

Published: 01 November 1996

View article titled, The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance

Journal Articles

Positive Methane-Producing Status Associated With Increased Serum Cholesterol in Subjects With Impaired Glucose Tolerance

Thomas M S Wolever, DM, Judlyn Fernandes, MSC, Venketeshwer A Rao, PHD, Jean-Louis Chiasson, MD, Robert G Josse, FRCP, Lawrence A Leiter, MD

Diabetes Care 1995;18(7):1010–1012

https://doi.org/10.2337/diacare.18.7.1010

Published: 01 July 1995

View article titled, Positive Methane-Producing Status Associated With Increased Serum Cholesterol in Subjects With Impaired Glucose Tolerance

NARROW

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339–1346

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes

Early Insulin Use in Type 2 Diabetes: What are the cons?

Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound

α-Glucosidase Inhibitors for Patients With Type 2 Diabetes: Response to van de Laar et al.

Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: Results of a 6-month, randomized, comparative trial

Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications

The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro)

Effect of Continuous Subcutaneous Insulin Infusion With Lispro on Hepatic Responsiveness to Glucagon in Type 1 Diabetes

The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data

No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA_1c or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate

Variation of Postprandial Plasma Glucose, Palatability, and Symptoms Associated With a Standardized Mixed Test Meal Versus 75 g Oral Glucose

Counterregulatory Hormone Responses After Long-Term Continuous Subcutaneous Insulin Infusion With Lispro Insulin

The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance

Positive Methane-Producing Status Associated With Increased Serum Cholesterol in Subjects With Impaired Glucose Tolerance

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only